chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea, shortness of breath, cough, headache, fatigue.  Symptoms severe and present every day.  Started in December before vaccines.  Drs think they may be related to COVID I had in November.  Symptoms only lack of food taste and fatigue.  My cardiologist had a case very similar to mine with slight symptoms with COVID.  I have had many, many tests and they are negative.
developed small red flat rash on abdomen, back,arms, legs, buttocks. Temp 101 swollen tonsils, saw Dr at hospital. Was given rx for Amoxicillin. Took one dose Amoxicillin, than had swelling of upper lip. stopped Amoxicillin.
Information has been received from a physician concerning a 7 yr old black male with an allergy to erythromycin who on 29Sep00 was vaccinated in the left leg with a 0.5mL first dose of varicella virus vaccine live (lot 635207/0075K). There was no illness at the time of vaccination. On 15May05 the pt developed a breakout of herpes zoster. The breakout was described one lesion consisting of a raised red patch of vesicles about one by two centimeters in size. The lesion was located on the left trunk on the T10 dermatome at the anterior axillary line near the inferior edge of his rib cage. The pt had some swollen lymph nodes. The pt had a maximum temp of 98.3F. No pain or other symptomatic symptoms were reported. On 15May05 at 9:10AM the pt was seen in the office. He was treated with acyclovir ointment (Zovirax ointment). A specimen was taken from a vesicle for PCR, results not yet reported. A direct fluorescent antibody was not done. The pt had no history of chickenpox. There was no recent exposure to chickenpox or herpes zoster. At the time of the report the pt had recovered. There was no product quality complaint involved. Follow up information indicated that the specimen was inadequate. The pt's adverse experience was considered an other important medical event (OMIC). Additional information is not expected.
Parent stated" her leg is swollen, painful to the touch and slight fever, I called Peds and they told me to place cool wash cloths for 15-20 min. It was not getting better so I took her back to the Health Department to see if someone could see her." Patient seen in the Pediatric Department on 11/16/2009 by "PAC Temp. 99.2 HR 108 RESP. 16 Patient recieved vaccine in right upper thigh 3 days ago subsquently she developed redness swelling tenderness in right thigh temp. 100.3 2 days ago and yesterday none today. Plan: continue Motrin every 6 hours D/C warm Compress rtc in 2 days for repaeat eval or sooner if worsens."
Pt had syncopal episode lasting 7 seconds after injection. Pt then became alert, oriented and denied any complaints. Pt taken immediately to the ER.
I was vaccinated with the flu vaccine at my local ymca at 9:00 a.m. on Saturday morning.11/03/2007.Shortly thereafter shot was administered on 11/04-2007 during the night,began experiencing severe allergic respiratory symptoms.Wheezing,whistling,coughing,chest congestion,etc.I have not experienced this for the last 3 yrs,since I stopped smoking.It felt bad.The same way I felt upon quitting.I did report it to my health care provider who suggested cough medicine as treatment.Will call back to double check on symptoms.Hopefully they will only be a couple of days duration.I thought I would report said symptoms.I am a single female 49 yrs of age.I do not smoke and have not done so in 3 yrs.
Large red, swollen, itchy area at injection site about 3 inches in diameter.  It came on gradually during the course of the day and was very noticeable the next morning. Also, experienced chills, muscle aches and headache during the night of the vaccination and through most of the next day. Today is the second day after all symptoms resolved except the red itchy area on arm. Still pretty large and itchy (also some hardness to the area). I don't normally have reactions at all to flu shots or other vaccinations so it's just a little surprising.
Had COVID after vaccination; Had COVID after vaccination; This is a spontaneous report received from a contactable reporter(s) (Other HCP) for a Pfizer sponsored program (169752).  A female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Had COVID after vaccination". Lack of efficacy of COVID vaccine. Also generalized that they'd seen lots of patients who were fully vaccinated but still contracted COVID.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information currently available, a lack of efficacy with bnt162b2 in this patient cannot be completely excluded.
No AE reported at this time; temperature excursion occured; This spontaneous report was received from a physician referring to a 12-year-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 18-JUN-2021 (also reported as between 03-JUN-2021 and 04-JUN-2021), the vaccine hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # 1659422, expiration date 04-SEP-2022), underwent a temperature excursion below 2 degrees Celsius (C), at -51.0 C) for 14 hours. No adverse event (AE) was experienced. No previous temperature excursions were reported, and a digital data logger was not involved.  This is one of several report provided by the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1659422; expirationdate: 04-SEP-2022; deviceage and unit: 0 ; malfunction: Unknown; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability; Sender's Comments:  US-009507513-2107USA002504: US-009507513-2107USA003379: US-009507513-2107USA002641:
Information has been received from a consumer concerning her 20 year old daughter.  Concomitant therapy included birth control (therapy unspecified).  The patient has a comprised immune system and allergies to penicillin and Neosporin.  On 16-Nov-2007 the patient was vaccinated with her first dose of Gardasil via injection (Lot number not specified).  On the evening of 16-Nov-2007 the patient experienced dizziness and developed diarrhea and vomiting.  The consumer reported that her daughter was beginning to feel better on 18-Nov-2007, but the vomiting returned on 19-Nov-2007.  The patient sought medical attention and had not recovered.  No further information was provided.  Additional information has been requested.
In the place of varicella vaccination 1 week after vaccination developed single papule which switched to vesicles filled with fluid. Clear fluid running out after and lesion partially worsened with CMA.
p/vax pt devel an inj site rxn characterizd by redness & swelling;no further ino was available @ the time of this report;this is one of two pt from this site to exp an adverse event rxn p/vax;
pt recv vax & 29APR96 pt presented to MD office w/rash of approx 60 lesions on scalp, arms & legs, low grade fever, h/a,  stiff neck & gen malaise;
Extremely painful and heavy menstrual cycles followed the vaccine (March 25th, April 28th, May 27th). This is not the norm for my body to experience.
She was given Flu vaccine Afluria by her CN at 2230. She experienced tightening of her throat, had some soup, brush her teeth thinking her mouth is dry and noted tonque start to feel swollen. She took 50mg. Benadryl p.o. took a nap during her lunch break at 3am. when she woke up her face, lips were numb swollen and her arm where vaccine was administered was sore , hot to touch but no redness. She was taken to ER for medical evaluation at 5:30AM. She was given Pepcid, Atarax and Prednisone. She was observed for a couple hours and discharged home after at around 7AM with rx for Atarax and Pepcid
Patient presented to the outside hospital on 4/27/21 with lower extremity weakness which progressed to paralysis and back pain (which had been intermittent since Dec. 2020), but had started to become persistent and rapidly worsen starting around 4/24/21. Patient subsequently transferred to HCF on 4/28/21 for concerns of Guillain-Barré syndrome with recent COVID-19 vaccination (Moderna: first dose on 4/14/21) with lower extremity paraplegia lack of deep tendon reflexes. Unable to perform MRI due to type of pacemaker that patient has. Lumbar puncture done 5/1/21 was consistent with Guillain-Barré with elevated protein. However, patient had minimal improvement in symptoms despite full 5-day course of IVIG. During her hospitalization, concern emerged for central compression and after further imaging patient was subsequently found to have a T8 compression fracture, spinal mass, and severe spinal canal stenosis at the level of the compression fracture. Spinal biopsy completed suggestive of DLBCL. Hematology/Oncology were consulted, and chemotherapy initiated. Bone marrow biopsy done on 5/7/21 with results pending as of 5/11/21.
patient was administered the vaccine in his left arm, and that was the arm he was complaining of pain and "warmness"; patient was administered the vaccine in his left arm, and that was the arm he was complaining of pain and "warmness"; This spontaneous report has been received from a medical assistant and refers to a 58-year-old male patient. The patient was allergic to penicillin, ipratropium, and dicloxacillin. The patient's medical history was not provided.   On 21-JUL-2021 in the morning, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) lot # T036820, expiration date of 01-JUL-2022, 0.5 milliliter, intramuscularly in the left arm for prophylaxis (routine immunization).  On the same date in the afternoon, he started complaining of left arm pain and "warmness". The patient went to the emergency room and was "advised if the pain and warmness got worse to come back". It was stated that the patient was administered the vaccine in his left arm, and that was the arm he was complaining of pain and "warmness". The patient received an unspecified treatment.   The outcome of the events was unknown. The causality was not provided. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T036820; expirationdate: 01-JUL-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
1MAY mom noted inc bruising; given Ceclor for otitis; t102, platelets dec est 73,000, 12MAY platelet 111,000; 14-15MAY hospitalized for pneumonia;
The pt experienced a large, red, hot, swollen area starting 24 hours post vax with some itchiness.
One month after latest booster protecting from Omicron I had Covid (a different variant, possible BQ 1 or BQ1.11. After 5 days on an antiviral medication I no longer had symptoms: hacki.ng dry cough, sneezing, runny nose, tightness in chest.  Three days later the symptoms returned . treated in ER and was told I now have rebound Covid.
Feels like she is having an allergic reaction on face, arms and hands after 1st dose; Pin pricking and needling after 1st dose; Sweats after the 1st dose; Can barely sleep after the 1st dose; Chills after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Feels like she is having an allergic reaction on face, arms and hands after 1st dose), PARAESTHESIA (Pin pricking and needling after 1st dose), HYPERHIDROSIS (Sweats after the 1st dose), INSOMNIA (Can barely sleep after the 1st dose) and CHILLS (Chills after the 1st dose) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN LOW) for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Feels like she is having an allergic reaction on face, arms and hands after 1st dose), PARAESTHESIA (Pin pricking and needling after 1st dose), HYPERHIDROSIS (Sweats after the 1st dose), INSOMNIA (Can barely sleep after the 1st dose) and CHILLS (Chills after the 1st dose). At the time of the report, HYPERSENSITIVITY (Feels like she is having an allergic reaction on face, arms and hands after 1st dose), PARAESTHESIA (Pin pricking and needling after 1st dose), HYPERHIDROSIS (Sweats after the 1st dose), INSOMNIA (Can barely sleep after the 1st dose) and CHILLS (Chills after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. On 15-JAN-2016, at approximately 11:30 AM the patient was vaccinated with improperly stored ZOSTAVAX (dosing details were not reported) (lot # L028280 and expiration date 28-OCT-2016) at temperature 47F, possibly as much as 13 hours time frame. There was no previous temperature excursion. No adverse experience was reported. Additional information has been requested.
Patient informed pharmacy on 10/31/13 that she was not sure if she had had a reaction to her ZOSTAVAX. On 10/16/13 patient broke out in spotty rash on right arm. By 10/19/13 she said she had warm sensation between her thumb and forefinger and about 20, itchy, blistery spots. She did not run a fever. Everyday she would get a few more spots. Went to dermatologist for punch biopsy of one of bumps came back as superficial and deep perivascular mixed cell dermatitis with leukocytosis.
pt recv vax 4MAY95 & in JAN97 pt devel a mild breakthrough case of chickenpox;MD felt this was a vaccine failure;pt completely recovered;
Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site). At the time of the report, VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received their first Moderna vaccine on 01-MAR-2021 and experienced adverse events which included symptom pain at the injection site.  No Concomitant product use was reported. No treatment information was provided.
full body rash; This spontaneous case was reported by a patient and describes the occurrence of RASH (full body rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (full body rash). At the time of the report, RASH (full body rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided
Patient reported that about 3 hours after receiving injection, she developed body aches and chest heaviness.  No shortness of breath.
This spontaneous report as received from a physician refers to a 4 year old female patient who was overweight and with none drug reactions or allergies. On 30-SEP-2014 the patient was intradermally vaccinated with (Oka-Merck) PROQUAD (0.5 ml, in the arm, route of administration, lot number were not reported). On 30-SEP-2014 the patient developed a small 'welt' at the site of the injection. The reporter stated that the patient was also scheduled to receive a PPD tuberculosis skin test at the visit. This products had been drawn up into syringes and the physician thought she had the syringe for the a tuberculin PPD in her hand but it was actually (Oka-Merck) PROQUAD. The actual PPD was administered in the opposite arm intradermally. The outcome of the event was not reported. The relatedness between event and (Oka-Merck) PROQUAD was not reported. Additional information has been requested.
Information has been received from a Registered Nurse referring to a 11 month old (reported as 12 month old) female patient. On 17-FEB-2016 at 15:57, the patient was intramuscularly vaccinated with an improperly stored (Temperature: 32F - Time frame: 5 minutes) dose of RECOMBIVAX HB (third dose, lot # K0099553, dose was unknown) in right thigh. No adverse effect was reported. This is one of several reports received form the same reporter. Additional information is not expected as all correspondence was received.
Soreness throughout the entire body, headache, some trouble with regulating breathing-throat felt like it was closing up, fever, nausea, vomiting bile, fatigue
ACHINESS; LOW GRADE FEVER; This spontaneous report received from a consumer and concerned a 67 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: bundle branch block, post-traumatic stress disorder, and panic attacks. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included acetylsalicylic acid for as a precaution for blood clots.  On an unspecified date, the patient experienced achiness, and low grade fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the low grade fever and achiness was not reported. This report was non-serious. This case, from the same reporter is linked to 20210943927.
vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) in a 37-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in May 2020 and the estimated date of delivery was 30-Mar-2021. On 22-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 22-Feb-2021, EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other relevant concomitant medications included, Prenatal vitamins was reported.   Treatment information was not provided. The patient's date of positivity pregnancy test is on JUL 2020 and estimated date of conception is on JUN 2020. This is a case of product exposure during pregnancy with no associated adverse events for this 37-year-old female. Patient will continue to be contacted for further monitoring of the AEs during the pregnancy.; Sender's Comments: This is a case of product exposure during pregnancy with no associated adverse events for this 37-year-old female. Patient will continue to be contacted for further monitoring of the AEs during the pregnancy.
Per mom once patient was home the area were she received Dtap on thigh had red raised area the size of a golf ball, with even larger redness around that, it lasted several days before clearing up. Per patients mother this is the 3rd reaction for Dtap containing vaccine, each time the reaction gets larger and larger.
no feeling in her right ring and right pinkie finger; started having complaints in her right arm that day of her arm feeling hot and tingling as if it had fallen asleep and it stayed like that all night; started having complaints in her right arm that day of her arm feeling hot and tingling as if it had fallen asleep and it stayed like that all night; This is a spontaneous report from a contactable consumer.  A 36 years old female patient received bnt162b2 (Comirnaty,Solution for injection, Batch/Lot number was not reported, Expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 01Sep2021 as dose 2, single (At the age of 36 years) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (Comirnaty, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) dose 1 via an unspecified route of administration, administered in unspecified date as dose 1,single for covid-19 immunization. On 01Sep2021, in her left arm and started having complaints in her right arm that day of her arm feeling hot and tingling as if it had fallen asleep and it stayed like that all night, but now she has no feeling in her right ring and right pinkie finger. On 02Sep2021, the event started having complaints in her right arm that day of her arm feeling hot and tingling as if it had fallen asleep and it stayed like that all night was resolved. At the time of reporting, the outcome of the event no feeling in her right ring and right pinkie finger was unknown.    The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
This spontaneous report was received from an administrator concerning a patient of unknown age and gender. Pertinent medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On 17-AUG-2017, the patient was vaccinated with an improperly stored dose of PEDVAXHIB injection, lot # M025194 for prophylaxis (strength, dose, dosage schedule, anatomical location and expiry date were not provided). No adverse effects reported. It was reported that the vaccine underwent a temperature excursion of 28° F during a time frame of 48 hours. No previous temperature excursion and data logger "yes" were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1806USA012918: US-009507513-1807USA001050.